Yahoo · Aug 31, 2026
LifeVantage (LFVN) Q4 2026 Earnings Call Transcript
Revenue fell 23% as macroeconomic pressures weighed on orders and average order sizes.
LF
NASDAQ · LFVN
LifeVantage Corporation
Consumer Defensive · Packaged Foods
$6.37
Down-$0.14 (-2.15%)
Updated Sep 11, 2026, 12:53 PM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 82.79M
- P/E ratio
- 7.98
- Dividend yield
- 2.75%
- 52-week range
- $3.90 – $11.71
- Volume
- 30.27K
- Avg. volume
- 161.66K
Price performance
LFVN price history
1M range · 20 trading sessions · Daily adjusted prices
LFVN closed at $6.37 after 20 trading sessions, down 1.85% for the selected period.
- Last close
- $6.37
- Period change
- -1.85%
- Period low
- $6.11
- Period high
- $6.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $6.57 | $6.58 | $6.2616 | $6.37 | 30.27K |
| Sep 9, 2026 | $6.34 | $6.69 | $6.30 | $6.51 | 67.98K |
| Sep 8, 2026 | $6.20 | $6.76 | $6.20 | $6.34 | 105.87K |
| Sep 4, 2026 | $6.11 | $6.29 | $6.11 | $6.25 | 12K |
| Sep 3, 2026 | $6.19 | $6.345 | $6.095 | $6.105 | 18.87K |
| Sep 2, 2026 | $6.15 | $6.37 | $6.11 | $6.13 | 50.59K |
| Sep 1, 2026 | $6.19 | $6.4899 | $6.10 | $6.23 | 62.66K |
| Aug 31, 2026 | $6.28 | $6.38 | $6.0246 | $6.33 | 54.54K |
| Aug 28, 2026 | $6.00 | $6.625 | $5.86 | $6.355 | 112.94K |
| Aug 27, 2026 | $6.58 | $6.62 | $6.24 | $6.45 | 102.02K |
| Aug 26, 2026 | $6.83 | $6.84 | $6.50 | $6.61 | 53.83K |
| Aug 25, 2026 | $6.78 | $6.90 | $6.5701 | $6.84 | 38.99K |
| Aug 24, 2026 | $6.63 | $6.85 | $6.58 | $6.84 | 38.78K |
| Aug 21, 2026 | $6.62 | $6.80 | $6.4934 | $6.69 | 40.35K |
| Aug 20, 2026 | $6.55 | $6.6997 | $6.44 | $6.65 | 46.12K |
| Aug 19, 2026 | $6.37 | $6.60 | $6.37 | $6.50 | 52.34K |
| Aug 18, 2026 | $6.49 | $6.5999 | $6.36 | $6.37 | 31.77K |
| Aug 17, 2026 | $6.59 | $6.6299 | $6.395 | $6.52 | 42.26K |
| Aug 14, 2026 | $6.45 | $6.6899 | $6.37 | $6.57 | 44.29K |
| Aug 13, 2026 | $6.49 | $6.6835 | $6.37 | $6.49 | 40.32K |
Latest LFVN news
The latest Smart Investors Daily articles mentioning LFVN.
Stock researchCompany · Overview
LFVN research
Overview
Company profile and research snapshot.
Company profile
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $12.00
- Implied upside
- —
- Analysts
- 8
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 28, 2026 | Lake Street | Hold | — |
| May 7, 2026 | Lake Street | Hold | — |
| Jan 14, 2025 | Craig-Hallum | Buy | — |
| Dec 19, 2024 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 28, 2026
LifeVantage Corporation Q4 2026 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q4 2026 earnings call
Benzinga · Aug 28, 2026
Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6
Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
Yahoo · Aug 28, 2026
Lifevantage Corp (LFVN) (Q4 2026) Earnings Call Highlights: Revenue Declines 23% Amid Strategic ...
New CEO outlines turnaround plan as subscription base remains resilient despite macroeconomic headwinds
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
